Effect of bariatric surgery on heart failure

Marcela Rodriguez Flores1, Carlos Aguilar Salinas1, Marie-Eve Piché2,3

  • 1a Endocrinology Department , Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" , Mexico.

Insights

Obesity significantly increases heart failure risk. Bariatric surgery shows promise in improving cardiac function for severely obese patients with heart failure, unlike modest weight loss.

Area of Science:

  • Cardiovascular Disease
  • Obesity Medicine
  • Cardiomyopathy Research

Background:

  • Obesity is a major risk factor for heart failure (HF), impacting cardiovascular health across younger populations.
  • Adipose tissue influences cardiac function through insulin resistance, adipokine signaling, and inflammation, potentially causing cardiomyopathy.
  • Current therapeutic strategies lack a single obesity-related pathway to effectively ameliorate cardiomyopathy in obese patients.

Purpose of the Study:

  • To review the therapeutic landscape for cardiomyopathy in obese patients.
  • To evaluate the impact of weight loss interventions, including bariatric surgery, on heart failure outcomes in severe obesity.

Main Methods:

  • Review of existing literature on obesity, heart failure, and weight loss interventions.
  • Analysis of observational studies and case reports concerning bariatric surgery in severely obese patients with HFpEF and HFrEF.
  • Consideration of bariatric surgery as a rescue treatment and bridge to heart transplantation.

Main Results:

  • Limited evidence supports long-term benefits of non-surgical weight loss on HF outcomes.
  • Observational studies indicate bariatric surgery improves cardiac structure and function in severely obese patients with HFpEF and HFrEF.
  • Positive outcomes reported for bariatric surgery as rescue treatment in severe obesity and HF, including as a bridge to transplantation.

Conclusions:

  • The rising prevalence of obesity necessitates interventions to mitigate cardiac damage.
  • Bariatric surgery is a viable option for reducing morbidity associated with heart failure in severely obese adults.
  • Further research is needed to identify and develop targeted obesity-related pathways for cardiomyopathy treatment.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
590
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
419
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K